特朗普称药价下调1500%，美媒：患者吃药还有钱挣？

Core Viewpoint - The article discusses President Trump's exaggerated claims about drug price reductions, stating that he claimed reductions of up to 1500%, which are mathematically impossible and not supported by evidence [1]. Drug Pricing Claims - Trump stated that drug prices have been reduced by 1200%, 1300%, 1400%, and 1500%, which is fundamentally flawed as it implies patients would be paid to take medication rather than paying for it [1]. - Experts have indicated that there is no evidence of such significant price reductions in the pharmaceutical market [1]. Expert Opinions - Marianne Sokol, a professor at Johns Hopkins University, expressed difficulty in translating Trump's claims into actual prices seen by patients at pharmacies, highlighting the illogical nature of the statements [1]. - The article emphasizes that the majority of prescription drug prices in the U.S. remain higher than those in other high-income countries [1]. Industry Response - Trump has reached out to 17 pharmaceutical companies, urging them to lower prescription drug costs in the U.S. to match the lowest prices found in other developed countries [1].